Andrew Huberman· PhD
And you know, all of these are places where you can identify something that is potentially, you know, mitigate something proactively before there's, you know, a problem. And especially with like neural degeneration, we're really just getting to a place where there's pharmacological, you know, opportunities to slow something down. And you want to find that as quick as possible.